1.
Protein & Cell
;
(12): 157-159, 2015.
Artigo
em Inglês
| WPRIM
| ID: wpr-757597
RESUMO
Nuclease-based genome editing has proven to be a powerful and promising tool for disease modeling and gene therapy. Recent advances in CRISPR/Cas and TALE indicate that they could also be used as a targeted regulator of gene expression, as well as being utilized for illuminating specific chromosomal structures or genomic regions.